Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 743 Records) |
| Query Trace: Neoplasms and ALK[original query] |
|---|
| ALK, ROS1, RET and NTRK1-3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers. International journal of molecular sciences 2023 9 24 (17): . Rimma S Mulkidjan, Evgeniya S Saitova, Elena V Preobrazhenskaya, Karimat A Asadulaeva, Mikhail G Bubnov, Ekaterina A Otradnova, Darya M Terina, Sofia S Shulga, Darya E Martynenko, Maria V Semina, Evgeniya V Belogubova, Vladislav I Tiurin, Priscilla S Amankwah, Aleksandr S Martianov, Evgeny N Imyanit |
| Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data. JCO oncology practice 2023 8 OP2200611. Jeffrey A Scott, Jochen Lennerz, Melissa Lynne Johnson, Lucio N Gordan, Robert H Dumanois, Luca Quagliata, Lauren L Ritterhouse, Federico Cappuzzo, Brandon Wang, Mei Xue, Anupama Vasudevan, Prateesh Varughese, Varun Vaidya, Mike Gart, Natalie Dorrow, Hinco J Gierman, Rushir J Chok |
| A randomized double-blind trial of TQB2450 with or without anlotinib in pretreated driver-negative non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2023 8 184 107353. Wei Zhang, Jing Wang, Qiming Wang, Ying Cheng, Lei Yang, Yuechuan Li, Hua Zhong, Tianqing Chu, Yu Dong, Yanwei Zhang, Fangfei Qian, Liwen Xiong, Chunlei Shi, Cuicui Zhang, Zhen He, Jing Zhu, Xiting Liu, Hui Ma, Kai Li, Baohui H |
| Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer. Cancer genomics & proteomics 2023 8 20 (5): 417-432. Yaroslav Ilnytskyy, Lars Petersen, John B McIntyre, Mie Konno, Adrijana D'Silva, Michelle Dean, Anifat Elegbede, Andrey Golubov, Olga Kovalchuk, Igor Kovalchuk, Gwyn Be |
| Case report: ALK D1225N missense mutation in lung adenocarcinoma responds to tyrosine kinase inhibitors. Frontiers in pharmacology 2023 8 14 1190447. Jianxin Chen, Junhui Wa |
| Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications. Lung cancer (Amsterdam, Netherlands) 2023 8 184 107317. Huriye Seker-Cin, Timothy Kwang Yong Tay, Daniel Kazdal, Klaus Kluck, Markus Ball, Olaf Neumann, Hauke Winter, Felix Herth, Claus-Peter Heußel, Rajkumar Savai, Peter Schirmacher, Michael Thomas, Jan Budczies, Michael Allgäuer, Petros Christopoulos, Albrecht Stenzinger, Anna-Lena Volckm |
| Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 8 . Luis Lara-Mejía, Andrés F Cardona, Luis Mas, Claudio Martín, Suraj Samtani, Luis Corrales, Graciela Cruz-Rico, Jordi Remon, Marco Galvez-Nino, Rossana Ruiz, Eduardo Rios-Garcia, Fernanda Tejada, Natalia Lozano-Vazquez, Rafael Rosell, Oscar Arrie |
| TP53 Exon 5 Mutation Indicates Poor Progression-Free Survival for Patients with Stage IV NSCLC. Frontiers in bioscience (Landmark edition) 2023 8 28 (7): 147. Huijing Feng, Huiru Xu, Xiuhuan Shi, Guobin Ding, Cihui Yan, Linhan Li, Zuoyi Jian, Xuejing Yang, Hongxia Guo, Feng Li, Junping Zhang, Xiubao R |
| Features of anaplastic lymphoma kinase rearrangement in early-stage lung cancer: Analysis of a nationwide Japanese database. Journal of surgical oncology 2023 7 . Yosuke Matsuura, Mingon Mun, Yasushi Shintani, Jiro Okami, Hiroyuki Ito, Takashi Ohtsuka, Takeshi Mori, Shun-Ichi Watanabe, Masayuki Chida, Shunsuke Endo, Ryoichi Nakanishi, Mitsutaka Kadokura, Hidemi Suzuki, Etsuo Miyaoka, Ichiro Yoshino, Hiroshi Date, |
| Next Generation Sequencing Analysis and its Benefit for Targeted Therapy of Lung Adenocarcinoma. Cancer genomics & proteomics 2023 7 20 (4): 404-411. Vlastimil Kulda, Jiri Polivka, Martin Svaton, Tomas Vanecek, Marcela Buresova, Katerina Houfkova, Mahyar Sharif Bagheri, Tereza Knizkova, Bohuslava Vankova, Jindra Windrichova, Petr Macan, Vaclav Babuska, Martin Pes |
| Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status. Brain sciences 2023 7 13 (7): . Bihong T Chen, Taihao Jin, Ningrong Ye, Sean W Chen, Russell C Rockne, Stephanie Yoon, Isa Mambetsariev, Ebenezer Daniel, Ravi Salg |
| Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC? Journal of cancer research and clinical oncology 2023 7 . Gürkan Güner, Burak Yasin Akta?, Fatma Bu?dayc? Ba?al, Ahmet Demirkaz?k, P?nar Gürsoy, Umut Demirci, Mustafa Erman, Perran Fulden Yumuk, Filiz Çay ?enler, Burcu Çakar, ?rfan Çiçin, Ak?n Öztürk, Hasan ?enol Co?kun, Erdem Çubukçu, Abdurrahman I??kdo?an, Ömer Fatih Ölmez, Ali Murat Tatl?, Mustafa Karaa?aç, Teoman ?akalar, Ye?im Eralp, Taner Korkmaz, Saadettin K?l?çk |
| Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers. BMC cancer 2023 7 23 (1): 659. Chong Kin Liam, Chian Yih Yew, Yong Kek Pang, Chee Kuan Wong, Mau Ern Poh, Jiunn Liang Tan, Chun Ian Soo, Thian Chee Loh, Ka Kiat Chin, Vijayan Munusamy, Yong Sheng Liam, Nur Husna Ibrah |
| Early ctDNA dynamics and efficacy of lorlatinib in patients with treatment-naïve, advanced, ALK-positive non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 6 . Ross A Soo, Jean-François Martini, Anthonie J van der Wekken, Shunsuke Teraoka, Roberto Ferrara, Alice T Shaw, Deborah Shepard, Anna Maria Calella, Anna Polli, Francesca Toffalorio, Pascale Tomasini, Chao-Hua Chiu, Dariusz Kowalski, Hye Ryun Kim, Benjamin J Solom |
| Supratentorial Sporadic Hemangioblastoma: A Case Report With Mutation Profiling Using Next-Generation DNA Sequencing. Cureus 2023 6 15 (6): e39818. Mohiuddin M Taher, Najwa A Bantan, Mustafa H Alwalily, Muhammad Saeed, Nuha M Taher, Meriem Bouzidi, Raid A Jastania, Kamal B Balkhoyo |
| Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations. Cancer research communications 2023 6 3 (6): 1026-1040. Kazunori Aoki, Yukari Nishito, Noriko Motoi, Yasuhito Arai, Nobuyoshi Hiraoka, Tatsuhiro Shibata, Yukiko Sonobe, Yoko Kayukawa, Eri Hashimoto, Mina Takahashi, Etsuko Fujii, Takashi Nishizawa, Hironori Fukuda, Kana Ohashi, Kosuke Arai, Yukihiro Mizoguchi, Yukihiro Yoshida, Shun-Ichi Watanabe, Makiko Yamashita, Shigehisa Kitano, Hiromi Sakamoto, Yuki Nagata, Risa Mitsumori, Kouichi Ozaki, Shumpei Niida, Yae Kanai, Akiyoshi Hirayama, Tomoyoshi Soga, Toru Maruyama, Keisuke Tsukada, Nami Yabuki, Mei Shimada, Takehisa Kitazawa, Osamu Natori, Noriaki Sawada, Atsuhiko Kato, Teruhiko Yoshida, Kazuki Yasuda, Hideaki Mizuno, Hiroyuki Tsunoda, Atsushi Ochi |
| Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. Thoracic cancer 2023 6 . Xiya Ma, Kun Zhang, Jing Xu, Hongjun Gao, Shaoxing Yang, Haifeng Qin, Hong Wang, Fang Gao, Xiaoqing L |
| Significance of the FGFR3 mutation in Chinese patients with bladder cancer. Translational andrology and urology 2023 6 12 (5): 761-769. Lanxiang Hao, Jiang Fang, Ran Xu, Shuo Liu, Guangcheng Luo, Xinjun Wa |
| Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer. Journal of cancer research and therapeutics 2023 5 19 (Supplement): S183-S190. Berna Komurcuoglu, Gamze Karakurt, Ozge O Kaya, Gulden Diniz, Ozgür K?rb?y?k, Aysen Evkan, Enver Yaln |
| Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients. Pathology oncology research : POR 2023 5 29 1610951. Adi Horesh, Rena Pollack, Hovav Nechushtan, Rivka Dresner-Pollak, Tzahi Neum |
| Comparison of First-Line Radiosurgery for Small-Cell and Non-Small Cell Lung Cancer Brain Metastases (Cross-FIRE). Journal of the National Cancer Institute 2023 5 . Chad G Rusthoven, Alyse W Staley, Dexiang Gao, Shoji Yomo, Denise Bernhardt, Narine Wandrey, Rami El Shafie, Anna Kraemer, Oscar Padilla, Veronica Chiang, Andrew M Faramand, Joshua D Palmer, Brad E Zacharia, Rodney E Wegner, Jona A Hattangadi-Gluth, Antonin Levy, Kenneth Bernstein, David Mathieu, Daniel N Cagney, Michael D Chan, Inga S Grills, Steve Braunstein, Cheng-Chia Lee, Jason P Sheehan, Christien Kluwe, Samir Patel, Lia M Halasz, Nicolaus Andratschke, Christopher P Deibert, Vivek Verma, Daniel M Trifiletti, Christopher P Cifarelli, Jürgen Debus, Stephanie E Combs, Yasunori Sato, Yoshinori Higuchi, Kyoko Aoyagi, Paul D Brown, Vida Alami, Ajay Niranjan, L Dade Lunsford, Douglas Kondziolka, D Ross Camidge, Brian D Kavanagh, Tyler P Robin, Toru Serizawa, Masaaki Yamamo |
| EGFR-Driven Mutation in Non-Small-Cell Lung Cancer (NSCLC) Influences the Features and Outcome of Brain Metastases. Journal of clinical medicine 2023 5 12 (10): . Daniele Armocida, Alessandro Pesce, Mauro Palmieri, Fabio Cofano, Giuseppe Palmieri, Paola Cassoni, Carla Letizia Busceti, Francesca Biagioni, Diego Garbossa, Francesco Fornai, Antonio Santoro, Alessandro Fra |
| Association of PD-L1 expression with efficacy of alectinib in advanced NSCLC patients with ALK fusion. Lung cancer (Amsterdam, Netherlands) 2023 5 181 107233. Yingying Pan, Xinyu Liu, Wei Zhang, Wanying Wang, Haowei Wang, Libo Luo, Keyi Jia, Chuchu Shao, Shiqi Mao, Tianyu Qiu, Jun Ni, Jia Yu, Lei Wang, Bin Chen, Anwen Xiong, Guanghui Gao, Xiaoxia Chen, Fengying Wu, Caicun Zhou, Chunyan Wu, Shengxiang R |
| Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study. Journal of the Egyptian National Cancer Institute 2023 4 35 (1): 7. Ismail Mohamed Said, Kassem Loay, Ali Ahmed Al-Husseiny, Ahmed Fatma Elzahraa, Shalaby Mohamed, Magdy Sal |
| A systematic review of genetic ancestry as a risk factor for incidence of non-small cell lung cancer in the US. Frontiers in genetics 2023 4 14 1141058. Breanna A James, Jennie L Williams, Barbara Nemesu |
| Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting. BMC cancer 2023 4 23 (1): 352. Julian Cristina, Pal Navdeep, Gershon Anda, Evangelista Marie, Purkey Hans, Lambert Peter, Shi Zhen, Zhang Qi |
| The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 2023 4 616 (7957): 525-533. Frankell Alexander M, Dietzen Michelle, Al Bakir Maise, Lim Emilia L, Karasaki Takahiro, Ward Sophia, Veeriah Selvaraju, Colliver Emma, Huebner Ariana, Bunkum Abigail, Hill Mark S, Grigoriadis Kristiana, Moore David A, Black James R M, Liu Wing Kin, Thol Kerstin, Pich Oriol, Watkins Thomas B K, Naceur-Lombardelli Cristina, Cook Daniel E, Salgado Roberto, Wilson Gareth A, Bailey Chris, Angelova Mihaela, Bentham Robert, Martínez-Ruiz Carlos, Abbosh Christopher, Nicholson Andrew G, Le Quesne John, Biswas Dhruva, Rosenthal Rachel, Puttick Clare, Hessey Sonya, Lee Claudia, Prymas Paulina, Toncheva Antonia, Smith Jon, Xing Wei, Nicod Jerome, Price Gillian, Kerr Keith M, Naidu Babu, Middleton Gary, Blyth Kevin G, Fennell Dean A, Forster Martin D, Lee Siow Ming, Falzon Mary, Hewish Madeleine, Shackcloth Michael J, Lim Eric, Benafif Sarah, Russell Peter, Boleti Ekaterini, Krebs Matthew G, Lester Jason F, Papadatos-Pastos Dionysis, Ahmad Tanya, Thakrar Ricky M, Lawrence David, Navani Neal, Janes Sam M, Dive Caroline, Blackhall Fiona H, Summers Yvonne, Cave Judith, Marafioti Teresa, Herrero Javier, Quezada Sergio A, Peggs Karl S, Schwarz Roland F, Van Loo Peter, Miedema Daniël M, Birkbak Nicolai J, Hiley Crispin T, Hackshaw Allan, Zaccaria Simone, , Jamal-Hanjani Mariam, McGranahan Nicholas, Swanton Charl |
| Molecular genetics of diffuse sclerosing papillary thyroid cancer. The Journal of clinical endocrinology and metabolism 2023 3 . Alswailem Meshael, Alghamdi Balgees, Alotaibi Anwar, Aljomiah Abeer, Al-Hindi Hindi, Murugan Avaniyapuram Kannan, Abouelhoda Mohamed, Shi Yufei, Alzahrani Ali |
| Childhood Exposure to Excess Ionizing Radiation Is Associated with Dose-Dependent Fusions as Molecular Drivers of Papillary Thyroid Cancer. Clinical thyroidology 2023 3 34 (4): 161-164. Klubo-Gwiezdzinska Joan |
| Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study. Frontiers in oncology 2023 3 13 1113696. Gow Chien-Hung, Hsieh Min-Shu, Chen Yi-Lin, Liu Yi-Nan, Wu Shang-Gin, Shih Jin-Yu |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: